Stem Cell Therapy Offers New Hope for Type 2 Diabetes Patients
For people at risk of the devastating ulcers and gangrene associated with type 2 diabetes, stem cell therapy could offer some hope for a new, effective therapy, according to research just published from Mount Sinai Hospital.
In the study, damaged muscle and blood vessels in mice with peripheral vascular disease showed “substantial” rapid healing after the injection of human umbilical cord blood stem cells. The research was lead by Associate Scientist Dr. Ian Rogers (photo) of the Lunenfeld-Tanenbaum Research Institute at Mount Sinai. It was published online (January 18, 2014) in Stem Cell Review and Report.
Entry filed under: Biotechnology News and Info from Canadian Universities. Tags: Diabetes, stem cell research.